Ashish Jha, BioRadar’s Co-Founder and CEO, has a new opinion piece in the Boston Globe, published Nov. 10: “A New Congress Should Mean a New Agenda for Health Care”. Ashish is a Senior Fellow at Harvard’s Belfer Center and a contributing Globe Opinion writer.
The piece argues that Washington has spent years debating who pays health care bills and should now ask why the bills are so high. On cost, he points to payment rules that reward inefficiency and calls for requiring Medicare to pay the same amount for the same care in any setting, stronger price transparency, and standardized electronic prior authorization. On science, he argues for stable NIH funding, funding decisions based on independent peer review, and statutory protections so government scientists can publish and communicate their findings.
Why it matters to the people we work with
- Public health departments. Federal funding and scientific independence shape what cities and counties can build on. The piece argues Congress can protect essential public health capabilities through appropriations.
- Health systems. Site-neutral payment, price transparency, and prior authorization are daily operating issues.
- Employers. Businesses pay the prices the piece is about.